Web14 ago 2013 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat central nervous system … Web22 ott 2024 · Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with …
Digital Therapeutics Foto e immagini stock - Getty Images
Web17 feb 2024 · February 16, 2024 07:45 PM Eastern Standard Time CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Sage Therapeutics (NASDAQ: SAGE) - On February 16, 2024, Chief Executive Officer Jeff Jonas conducted... Web22 mar 2024 · To be marketed as Zulresso, it’s the first drug developed by and approved from Sage Therapeutics of Cambridge, Mass. Jeff Jonas, Sage’s CEO, recently chatted with STAT about the drug, its... rituals cosmetics logo
Dr. Jeffrey Jonas Leads SAGE Therapeutics as New CEO
Web17 ott 2024 · BOSTON, October 17, 2024—Karuna Pharmaceuticals, Inc (“Karuna”), focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders marked by psychosis and cognitive impairment, today announced the appointment of industry leader Jeff Jonas, MD, CEO of Sage Therapeutics (NASDAQ: SAGE), as an … Web17 ott 2024 · Dr. Jonas is the Chief Executive Officer and a member of the Board of Directors at Sage Therapeutics. Before joining Sage, Dr. Jonas served as President of the Regenerative Medicine Division of ... Web6 dic 2024 · Biotech veteran Jeff Jonas on leaving Sage, guiding new biotechs and his ‘personal odyssey’ In an interview with BioPharma Dive, the longtime industry executive discussed becoming a biotech investor and his plans for Abio-X, a new incubator with $150 million to spend on startups. smith electric motorworks gwm